The prevalence and incidence of neurocognitive impairment in the HAART era
University of North Carolina at Chapel Hill · University of North Carolina Health Care · +4 more institutions
Abstract
HAART suppresses HIV viral replication and restores immune function. The effects of HAART on neurological disease are less well understood. The aim of this study was to assess the prevalence and incidence of neurocognitive impairment in individuals who initiated HAART as part of an AIDS clinical trial.
A prospective cohort study of HIV-positive patients enrolled in randomized antiretroviral trials, the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) study.
Citation impact
- FWCI
- 8.94
- Percentile
- 100%
- References
- 34
Authors
10- KRKevin R. RobertsonCorresponding
University of North Carolina at Chapel Hill, University of North Carolina Health Care
- MSMarlene Smurzynski
Cancer Research And Biostatistics
- TDThomas D. Parsons
University of North Carolina Health Care, University of North Carolina at Chapel Hill
- KWKunling Wu
Cancer Research And Biostatistics
- RJRonald J. Bosch
Cancer Research And Biostatistics
Topics & keywords
- Neurocognitive
- Medicine
- Immunosuppression
- Incidence (geometry)
- Clinical trial
- Internal medicine
- Disease
- Immunology
- Good health and well-being